Stockscreener 앱 받기
1.75%
전일 마감가:
$195.87
열려 있는:
$195.62
하루 거래량:
1.32M
Relative Volume:
0.33
시가총액:
$141.11B
수익:
$24.57B
순이익/손실:
$3.60B
주가수익비율:
39.43
EPS:
5.051
순현금흐름:
$5.26B
1주 성능:
+4.34%
1개월 성능:
+6.39%
6개월 성능:
-3.33%
1년 성능:
+3.28%
1일 변동 폭
$195.09
$200.40
1주일 범위
$188.06
$200.40
52주 변동 폭
$180.03
$242.80
다나허 Stock (DHR) Company Profile
명칭
Danaher Corp
전화
(202) 828-0850
주소
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
199.39 | 134.19B | 24.57B | 3.60B | 5.26B | 5.051 |
TMO
Thermo Fisher Scientific Inc
|
527.94 | 184.37B | 44.56B | 6.72B | 6.29B | 17.74 |
IDXX
Idexx Laboratories Inc
|
582.35 | 44.72B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
121.45 | 32.52B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
332.61 | 31.41B | 3.17B | 642.63M | 516.49M | 10.77 |
다나허 Stock (DHR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-02 | 개시 | Morgan Stanley | Overweight |
| 2025-10-08 | 다운그레이드 | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2025-03-14 | 업그레이드 | Stifel | Hold → Buy |
| 2025-02-03 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-12-19 | 개시 | Guggenheim | Buy |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-31 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2023-12-18 | 개시 | HSBC Securities | Hold |
| 2023-12-13 | 재개 | Wolfe Research | Peer Perform |
| 2023-12-07 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-01 | 개시 | SVB Securities | Outperform |
| 2023-04-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-10-24 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-08-17 | 재개 | Bernstein | Outperform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2022-06-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | 개시 | Bernstein | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-10 | 재확인 | BofA Securities | Buy |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-23 | 재확인 | Goldman | Buy |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-04-07 | 재개 | Robert W. Baird | Outperform |
| 2021-03-03 | 재개 | Barclays | Overweight |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 재개 | Stifel | Hold |
| 2019-10-28 | 재확인 | Needham | Buy |
| 2019-10-14 | 재개 | Credit Suisse | Outperform |
| 2019-07-19 | 재확인 | Needham | Buy |
| 2019-06-11 | 개시 | Piper Jaffray | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-04-17 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2019-02-25 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-03 | 개시 | Needham | Buy |
| 2018-04-20 | 재확인 | Stifel | Buy |
모두보기
다나허 주식(DHR)의 최신 뉴스
Norris Perne & French LLP MI Boosts Stake in Danaher Corporation $DHR - MarketBeat
JM2 Capital Inc. Takes $1.33 Million Position in Danaher Corporation $DHR - MarketBeat
Danaher (DHR) Projected to Post Earnings on Tuesday - MarketBeat
Danaher Corp (DHR) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
DHR Maintained by Goldman Sachs -- Price Target Lowered to $230 - GuruFocus
The Goldman Sachs Group Lowers Danaher (NYSE:DHR) Price Target to $230.00 - MarketBeat
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
State of Alaska Department of Revenue Decreases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes - PR Newswire
Best Biotech Stocks To Keep An Eye OnApril 12th - MarketBeat
Sumitomo Mitsui Trust Group Inc. Cuts Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat
What to expect from Danaher Corporation's Q1 2026 earnings report - MSN
Biotech Stocks To ResearchApril 11th - MarketBeat
Massachusetts Financial Services Co. MA Boosts Stake in Danaher Corporation $DHR - MarketBeat
Factory Mutual Insurance Co. Sells 5,500 Shares of Danaher Corporation $DHR - MarketBeat
Bar Harbor Wealth Management Has $14.72 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Promising Biotech Stocks To Follow TodayApril 10th - MarketBeat
GENERAL AMERICAN INVESTORS CO INC's Danaher Corp(DHR) Holding History - GuruFocus
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Douglas Lane & Associates LLC Grows Position in Danaher Corporation $DHR - MarketBeat
Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders? - Finviz
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Published on: 2026-04-10 13:38:44 - baoquankhu1.vn
Danaher Corporation (DHR) stock price, news, quote and history - Yahoo Finance UK
Masimo stock price target raised to $180 by Jefferies on Danaher deal - Investing.com Australia
Danaher Corporation $DHR Stock Holdings Cut by CCLA Investment Management - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
Support Test: Whats the beta of Danaher Corporation stockQuarterly Trade Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Biotech Stocks To Keep An Eye OnApril 8th - MarketBeat
Danaher Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape - Markets Mojo
Danaher (NYSE:DHR) Given New $230.00 Price Target at Wolfe Research - MarketBeat
Jefferies Financial Group Has Lowered Expectations for Danaher (NYSE:DHR) Stock Price - MarketBeat
9,123 Shares in Danaher Corporation $DHR Purchased by Oak Thistle LLC - MarketBeat
Sivik Global Healthcare LLC Trims Stock Holdings in Danaher Corporation $DHR - MarketBeat
GREENWOOD CAPITAL ASSOCIATES LLC's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corporation $DHR Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat
Evercore ISI Cuts Danaher (DHR) Price Target, Adds Shares to Tactical Outperform List - Insider Monkey
Biotech Stocks To Watch NowApril 7th - MarketBeat
Evaluating Danaher (DHR) After Mixed Recent Returns And Conflicting Undervaluation Signals - simplywall.st
Fulton Breakefield Broenniman LLC Reduces Stock Holdings in Danaher Corporation $DHR - MarketBeat
The Osterweis Fund's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corporation (DHR) Stock Price, News, Quote & History - ca.finance.yahoo.com
Danaher (DHR) Analyst Rating: Evercore ISI Lowers Price Target | - GuruFocus
Best Biotech Stocks To ConsiderApril 6th - MarketBeat
Danaher Corporation (DHR) Stock Forecasts - Yahoo Finance
Danaher: After a Long Reset Period, Profit Growth Looks Likely to Accelerate in the Medium Term - Morningstar
Evercore Cuts Danaher (NYSE:DHR) Price Target to $225.00 - MarketBeat
다나허 (DHR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.61%
자본화:
|
볼륨(24시간):